{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:46Z","timestamp":1773792046101,"version":"3.50.1"},"reference-count":34,"publisher":"BMJ","issue":"14","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2019,12,2]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>Patients with severe mitral stenosis (MS) and their clinicians typically choose percutaneous transvenous mitral commissurotomy (PTMC) over surgical commissurotomy (SC). However, the durability of PTMC relative to SC is uncertain. We compared the efficacy, safety and durability of PTMC with SC for the treatment of MS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We searched EMBASE, MEDLINE and WHO ICTRP registers for randomised controlled trials (RCTs) comparing PTMC, and open and\/or closed mitral commissurotomy. The principal outcomes were rate of re-intervention and symptomatic improvement as inferred from the surrogate measures of immediate postprocedural mitral valve area (MVA), MVA at \u22656\u2009month follow-up, incidence of mitral regurgitation (MR) and restenosis. We calculated weighted mean differences (WMD) for continuous outcomes, relative risks (RR) for binary outcomes and pooled outcomes using random-effects models and assessed the quality of evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Seven RCTs with 553 patients proved eligible. Pooled estimates showed no convincing difference in the risk of restenosis or re-intervention (15\/100 fewer with PTMC, 95%\u2009CI (\u221220 to +8); quality of evidence: moderate) or in symptoms as inferred from immediate MVA (WMD 0.15, 95%\u2009CI (\u22120.18 to 0.48): very low), from the incidence of postprocedural severe MR (3\/100 more with PTMC, 95%\u2009CI (\u22121 to +10): moderate) or from MVA at 30 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Until data demonstrating convincing superiority of SC over PTMC become available, our results support the current practice of recommending PTMC to young patients with MS and favourable valve morphology, as it is associated with lower peri-procedural morbidity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>PROSPERO 2017 (CRD42017079512).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2019-315906","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T17:24:25Z","timestamp":1579800265000},"page":"1094-1101","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Percutaneous mitral commissurotomy versus surgical commissurotomy for rheumatic mitral stenosis: a systematic review and meta-analysis of randomised controlled trials"],"prefix":"10.1136","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9094-1071","authenticated-orcid":false,"given":"Achintya Dinesh","family":"Singh","sequence":"first","affiliation":[{"name":"Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agrima","family":"Mian","sequence":"additional","affiliation":[{"name":"Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niveditha","family":"Devasenapathy","sequence":"additional","affiliation":[{"name":"Indian Institute of Public Health-, Delhi, Gurgaon, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-2917","authenticated-orcid":false,"given":"Ganesan","family":"Karthikeyan","sequence":"additional","affiliation":[{"name":"Cardiology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"key":"2025091922565615000_106.14.1094.1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(18)30999-1","article-title":"Acute rheumatic fever","volume":"392","author":"Karthikeyan","year":"2018","journal-title":"The Lancet"},{"key":"2025091922565615000_106.14.1094.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603693"},{"key":"2025091922565615000_106.14.1094.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024769"},{"key":"2025091922565615000_106.14.1094.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu449"},{"key":"2025091922565615000_106.14.1094.5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0140-6736(60)91479-3","article-title":"The risks of deferring valvotomy in patients with moderate mitral stenosis","volume":"276","author":"Bannister","year":"1960","journal-title":"The Lancet"},{"key":"2025091922565615000_106.14.1094.6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/CRD.0000000000000185","article-title":"Medical management of rheumatic heart disease: a systematic review of the evidence","volume":"26","author":"Russell","year":"2018","journal-title":"Cardiol Rev"},{"key":"2025091922565615000_106.14.1094.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.532498"},{"key":"2025091922565615000_106.14.1094.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx391"},{"key":"2025091922565615000_106.14.1094.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.537"},{"key":"2025091922565615000_106.14.1094.10","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2011.13180","article-title":"Systematic comparison of the effectiveness of percutaneous mitral balloon valvotomy with surgical mitral commissurotomy","volume":"141","author":"Hu","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"2025091922565615000_106.14.1094.11","doi-asserted-by":"crossref","unstructured":"Antunes MJ . Open mitral commissurotomy. Multimed Man Cardiothorac Surg 2006;2006.doi:10.1510\/mmcts.2004.000950","DOI":"10.1510\/mmcts.2004.000950"},{"key":"2025091922565615000_106.14.1094.12","unstructured":"Sch\u00fcnemann H , Bro\u017cek J , Guyatt G , et al Bro\u017cek J , Guyatt G , Oxman A , et al , eds. Grade Handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group, 2013. guidelinedevelopment.org\/handbook"},{"key":"2025091922565615000_106.14.1094.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2025091922565615000_106.14.1094.14","unstructured":"Singh A , Mian A , Devasenapathy N , et al . Comparison of immediate, intermediate and long-term outcomes of percutaneous transvenous mitral commissurotomy versus surgical commissurotomy: a systematic review and meta-analysis. Prospero 2017 CRD42017079512. Available: http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?ID=CRD42017079512 [Accessed 22 Feb 2019]."},{"key":"2025091922565615000_106.14.1094.15","unstructured":"Higgins J , Sterne J , Savovi\u0107 J , et al . A revised tool for assessing risk of bias in randomized trials. Cochrane Methods Cochrane Database Syst Rev 2016."},{"key":"2025091922565615000_106.14.1094.16","unstructured":"GRADEpro GDT . GRADEpro Guideline development tool. McMaster University (developed by evidence prime, Inc), 2015. Available: https:\/\/gradepro.org\/ [Accessed 30 Sep 2018]."},{"key":"2025091922565615000_106.14.1094.17","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(93)90118-S"},{"key":"2025091922565615000_106.14.1094.18","doi-asserted-by":"publisher","DOI":"10.1159\/000067320"},{"key":"2025091922565615000_106.14.1094.19","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90555-N"},{"key":"2025091922565615000_106.14.1094.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199410133311501"},{"key":"2025091922565615000_106.14.1094.21","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.3.245"},{"key":"2025091922565615000_106.14.1094.22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.4.1179"},{"key":"2025091922565615000_106.14.1094.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2008.08.003"},{"key":"2025091922565615000_106.14.1094.24","first-page":"415","article-title":"Comparison between percutaneous balloon valvuloplasty and open commissurotomy for mitral stenosis]","volume":"70","author":"Cardoso","year":"1998","journal-title":"Arq Bras Cardiol"},{"key":"2025091922565615000_106.14.1094.25","first-page":"248","article-title":"Comparison of open commissurotomy and balloon valvuloplasty in mitral stenosis. A five-year follow-up","volume":"83","author":"Cardoso","year":"2004","journal-title":"Arq Bras Cardiol"},{"key":"2025091922565615000_106.14.1094.26","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.60.4.299"},{"key":"2025091922565615000_106.14.1094.27","unstructured":"Higgins J , Green S . Cochrane Handbook for systematic reviews of interventions version 5.1.0. The Cochrane collaboration, 2011. Available: http:\/\/handbook.cochrane.org [Accessed 19 Jan 2019]."},{"key":"2025091922565615000_106.14.1094.28","first-page":"281","article-title":"Closed commissurotomy versus balloon valvuloplasty for rheumatic mitral stenosis","volume":"10","author":"Tokmakoglu","year":"2001","journal-title":"J Heart Valve Dis"},{"key":"2025091922565615000_106.14.1094.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.06.008"},{"key":"2025091922565615000_106.14.1094.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01726-0"},{"key":"2025091922565615000_106.14.1094.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020185"},{"key":"2025091922565615000_106.14.1094.32","first-page":"45","article-title":"Percutaneous mitral balloon valvuloplasty for patients with rheumatic mitral stenosis","volume":"1","author":"Palacios","year":"2012","journal-title":"Interv Cardiol Clin"},{"key":"2025091922565615000_106.14.1094.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2005.00045.x"},{"key":"2025091922565615000_106.14.1094.34","first-page":"66","article-title":"Immediate, intermediate and long term clinical outcomes of percutaneous transvenous mitral commissurotomy","volume":"6","author":"Murthy Jayanthi Sriram","year":"2015","journal-title":"Int J Cardiol Heart Vasc"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2019-315906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T05:57:09Z","timestamp":1758347829000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2019-315906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":34,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2020,6,25]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/heartjnl-2019-315906"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2019-315906","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,23]]}}}